50419-385 : Aliqopa 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC50419-385
Labeler: Bayer Healthcare Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Aliqopa
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA209936
Rev. Date: 


NDC Package Codes:

  • 50419-385-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (50419‑385‑01) > 4 ML IN 1 VIAL, SINGLE‑DOSE
  • 50419-385-72: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (50419‑385‑72) > 4 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Copanlisib

Dosage Strength:

  • 15 mg/mL

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Kinase Inhibitors [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50419-385 QR Code

< Prev: 50419-346Next: 50419-390 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 October 2017.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA